These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 29298863)
21. GST pi modulates JNK activity through a direct interaction with JNK substrate, ATF2. Thévenin AF; Zony CL; Bahnson BJ; Colman RF Protein Sci; 2011 May; 20(5):834-48. PubMed ID: 21384452 [TBL] [Abstract][Full Text] [Related]
22. Significance of MR/OPN/HMGB1 axis in NAFLD-associated hepatic fibrogenesis. Tang M; Jia H; Chen S; Yang B; Patpur BK; Song W; Chang Y; Li J; Yang C Life Sci; 2021 Jan; 264():118619. PubMed ID: 33091447 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway. Zhang T; Hu J; Wang X; Zhao X; Li Z; Niu J; Steer CJ; Zheng G; Song G J Hepatol; 2019 Jan; 70(1):87-96. PubMed ID: 30218679 [TBL] [Abstract][Full Text] [Related]
25. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1. Wang Y; Zhu K; Yu W; Wang H; Liu L; Wu Q; Li S; Guo J Biochem Biophys Res Commun; 2017 Nov; 493(1):227-232. PubMed ID: 28899784 [TBL] [Abstract][Full Text] [Related]
26. Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish. Lai CY; Lin CY; Hsu CC; Yeh KY; Her GM Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):844-856. PubMed ID: 29678641 [TBL] [Abstract][Full Text] [Related]
27. Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid. Yang YM; Seo SY; Kim TH; Kim SG Hepatology; 2012 Dec; 56(6):2209-20. PubMed ID: 22807119 [TBL] [Abstract][Full Text] [Related]
28. Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease. Lei L; Zhou C; Yang X; Li L Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):819-831. PubMed ID: 29569260 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPK Yu Y; He C; Tan S; Huang M; Guo Y; Li M; Zhang Q Anal Cell Pathol (Amst); 2021; 2021():4853355. PubMed ID: 35004133 [TBL] [Abstract][Full Text] [Related]
30. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation. Pan ZG; An XS Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967 [TBL] [Abstract][Full Text] [Related]
32. PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease. Rana R; Shearer AM; Fletcher EK; Nguyen N; Guha S; Cox DH; Abdelmalek M; Wang Y; Baleja JD; Covic L; Kuliopulos A Mol Metab; 2019 Nov; 29():99-113. PubMed ID: 31668396 [TBL] [Abstract][Full Text] [Related]
33. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1. Ao R; Wang Y; Tong J; Wang BF Med Sci Monit; 2016 Oct; 22():3804-3819. PubMed ID: 27756894 [TBL] [Abstract][Full Text] [Related]
34. Targeting hepatic miR-221/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice. Jiang X; Jiang L; Shan A; Su Y; Cheng Y; Song D; Ji H; Ning G; Wang W; Cao Y EBioMedicine; 2018 Nov; 37():307-321. PubMed ID: 30316865 [TBL] [Abstract][Full Text] [Related]
35. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease. Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862 [TBL] [Abstract][Full Text] [Related]
36. The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance. Zhang QY; Zhao LP; Tian XX; Yan CH; Li Y; Liu YX; Wang PX; Zhang XJ; Han YL Hepatology; 2017 Sep; 66(3):834-854. PubMed ID: 28508477 [TBL] [Abstract][Full Text] [Related]
37. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis. Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395 [TBL] [Abstract][Full Text] [Related]
38. Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin α8-mediated activation of RhoA signaling pathway. Cai Q; Chen F; Xu F; Wang K; Zhang K; Li G; Chen J; Deng H; He Q Metabolism; 2020 Mar; 104():154140. PubMed ID: 31926204 [TBL] [Abstract][Full Text] [Related]
39. Lipocalin 2 induces neuroinflammation and blood-brain barrier dysfunction through liver-brain axis in murine model of nonalcoholic steatohepatitis. Mondal A; Bose D; Saha P; Sarkar S; Seth R; Kimono D; Albadrani M; Nagarkatti M; Nagarkatti P; Chatterjee S J Neuroinflammation; 2020 Jul; 17(1):201. PubMed ID: 32622362 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice. Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]